Document reference

2021/2800(DEA)  
Evaluation of notifications by national competent authorities to the Commission and inclusion of cicatrizants with ATC code D03AX and pharmaceutical form fly larvae in the list of medicinal products that shall not bear the safety features  
Basic information  

2021/2800(DEA)

DEA - Delegated acts procedure

Supplementing 1999/0134(COD)

Subject
4.20.01 Medicine, diseases
4.20.04 Pharmaceutical products and industry

Status

Procedure completed - delegated act enters into force

 

Please go to Documentation gateway for any follow-up documents.: Please go to Documentation gateway for any follow-up documents. 
Key players  
Key events  
07/07/2021
Non-legislative basic document published
C(2021)04934
07/07/2021
Initial period for examining delegated act 2 month(s)
08/07/2021
Committee referral announced in Parliament
15/09/2021
Delegated act not objected by Parliament
Technical information  
Procedure reference
2021/2800(DEA)
Procedure type
DEA - Delegated acts procedure
Procedure subtype
Examination of delegated act
Stage reached in procedure
Procedure completed - delegated act enters into force
Committee dossier
ENVI/9/06772
Documentation gateway